Baxter Price to Sales Ratio 2010-2025 | BAX
Historical PS ratio values for Baxter (BAX) over the last 10 years. The current P/S ratio for Baxter as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Baxter P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-05-02 |
30.71 |
|
1.63 |
| 2025-03-31 |
34.23 |
$18.90 |
1.81 |
| 2024-12-31 |
29.02 |
$20.83 |
1.39 |
| 2024-09-30 |
37.59 |
$20.85 |
1.80 |
| 2024-06-30 |
32.87 |
$20.69 |
1.59 |
| 2024-03-31 |
41.63 |
$20.54 |
2.03 |
| 2023-12-31 |
37.39 |
$20.45 |
1.83 |
| 2023-09-30 |
36.21 |
$17.70 |
2.05 |
| 2023-06-30 |
43.41 |
$19.75 |
2.20 |
| 2023-03-31 |
38.37 |
$19.50 |
1.97 |
| 2022-12-31 |
47.88 |
$19.83 |
2.42 |
| 2022-09-30 |
50.34 |
$27.18 |
1.85 |
| 2022-06-30 |
59.73 |
$26.39 |
2.26 |
| 2022-03-31 |
71.82 |
$25.41 |
2.83 |
| 2021-12-31 |
79.25 |
$23.89 |
3.32 |
| 2021-09-30 |
73.98 |
$24.38 |
3.03 |
| 2021-06-30 |
73.78 |
$23.74 |
3.11 |
| 2021-03-31 |
77.03 |
$22.91 |
3.36 |
| 2020-12-31 |
73.05 |
$22.58 |
3.24 |
| 2020-09-30 |
72.98 |
$22.28 |
3.28 |
| 2020-06-30 |
77.90 |
$22.03 |
3.54 |
| 2020-03-31 |
73.26 |
$22.23 |
3.30 |
| 2019-12-31 |
75.26 |
$21.85 |
3.44 |
| 2019-09-30 |
78.52 |
$21.16 |
3.71 |
| 2019-06-30 |
73.33 |
$20.73 |
3.54 |
| 2019-03-31 |
72.59 |
$20.47 |
3.55 |
| 2018-12-31 |
58.62 |
$20.27 |
2.89 |
| 2018-09-30 |
68.46 |
$20.15 |
3.40 |
| 2018-06-30 |
65.41 |
$19.95 |
3.28 |
| 2018-03-31 |
57.46 |
$19.45 |
2.95 |
| 2017-12-31 |
56.97 |
$19.09 |
2.99 |
| 2017-09-30 |
55.17 |
$18.85 |
2.93 |
| 2017-06-30 |
53.09 |
$18.63 |
2.85 |
| 2017-03-31 |
45.35 |
$18.61 |
2.44 |
| 2016-12-31 |
38.68 |
$18.42 |
2.10 |
| 2016-09-30 |
41.40 |
$18.35 |
2.26 |
| 2016-06-30 |
39.22 |
$18.24 |
2.15 |
| 2016-03-31 |
35.52 |
$18.07 |
1.97 |
| 2015-12-31 |
32.89 |
$18.16 |
1.81 |
| 2015-09-30 |
28.24 |
$18.52 |
1.52 |
| 2015-06-30 |
32.55 |
$18.94 |
1.72 |
| 2015-03-31 |
31.89 |
$22.02 |
1.45 |
| 2014-12-31 |
34.12 |
$24.65 |
1.38 |
| 2014-09-30 |
33.41 |
$27.44 |
1.22 |
| 2014-06-30 |
33.66 |
$29.25 |
1.15 |
| 2014-03-31 |
34.25 |
$28.35 |
1.21 |
| 2013-12-31 |
32.38 |
$27.59 |
1.17 |
| 2013-09-30 |
30.58 |
$25.99 |
1.18 |
| 2013-06-30 |
32.24 |
$25.53 |
1.26 |
| 2013-03-31 |
33.81 |
$25.31 |
1.34 |
| 2012-12-31 |
31.03 |
$25.07 |
1.24 |
| 2012-09-30 |
28.06 |
$25.05 |
1.12 |
| 2012-06-30 |
24.74 |
$24.84 |
1.00 |
| 2012-03-31 |
27.83 |
$24.53 |
1.13 |
| 2011-12-31 |
23.03 |
$24.17 |
0.95 |
| 2011-09-30 |
26.13 |
$23.78 |
1.10 |
| 2011-06-30 |
27.79 |
$23.18 |
1.20 |
| 2011-03-31 |
25.03 |
$22.39 |
1.12 |
| 2010-12-31 |
23.56 |
$21.60 |
1.09 |
| 2010-09-30 |
22.21 |
$21.36 |
1.04 |
| 2010-06-30 |
18.92 |
$21.01 |
0.90 |
| 2010-03-31 |
27.09 |
$20.76 |
1.31 |
| 2009-12-31 |
27.32 |
$20.44 |
1.34 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$15.752B |
$10.636B |
|
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
|
